baloxavir marboxil 30 MG Granules for Oral Suspension [Xofluza]

RxNorm concept 2716800, branded drug (sbd). Prescribable name: Xofluza 30 MG Granules for Oral Suspension.

RxCUI: 2716800
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2716800 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

baloxavir marboxil 2099995

Other names

Xofluza 30 MG Granules for Oral Suspension

Related concepts

baloxavir marboxil 30 MG (SCDC, consists of)
baloxavir marboxil 30 MG [Xofluza] (SBDC, consists of)
Granules for Oral Suspension (DF, has dose form)
Xofluza (BN, has ingredient)
baloxavir marboxil 30 MG Granules for Oral Suspension (SCD, tradename of)

Linked data

NDCs

50242059901

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 2716800 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2716800 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2716800. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.